Cybin (HELP) Change in Accured Expenses (2020 - 2025)
Cybin (HELP) posted quarterly Change in Accured Expenses of $2.8 million for Q4 2025, down 35.15% year-on-year from $4.3 million in Q4 2024, and up 336.44% on a QoQ basis from -$1.2 million in Q3 2025.
Cybin (HELP) Change in Accured Expenses (2020 - 2025) Analysis & Trends
Cybin (HELP) has reported Change in Accured Expenses for 6 consecutive years, with $2.8 million the latest figure, recorded in Q4 2025.
- Quarterly Change in Accured Expenses fell 35.15% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.6 million (up 272.82% YoY) and the FY2023 annual result came in at -$855934.0, down 134.24% from the prior year.
- Change in Accured Expenses grew to $2.8 million in Q4 2025 per HELP's latest filing, from -$1.2 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for HELP reached as high as $4.3 million in Q4 2024 and fell as low as -$5.7 million in Q4 2023.
- A 5-year average of $120243.9 and a median of $210703.5 in 2021 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2021 — Change in Accured Expenses jumped 1329.3% — and 2024, when it sank 1620.53%.
- Year by year, Change in Accured Expenses stood at $330027.8 in 2021, then sank by 214.51% to -$377928.6 in 2022, then sank by 1414.63% to -$5.7 million in 2023, then soared by 175.86% to $4.3 million in 2024, then tumbled by 35.15% to $2.8 million in 2025.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $2.8 million, -$1.2 million, and -$347000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -16.82 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -16.74 Mn |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.82 Mn |
| Dec 31, 2025 | 2.82 Mn |
| Sep 30, 2025 | -1.19 Mn |
| Sep 30, 2025 | -1.19 Mn |
| Jun 30, 2025 | -347,000.00 |
| Jun 30, 2025 | -347,000.00 |
| Dec 31, 2024 | 4.34 Mn |
| Dec 31, 2024 | 4.34 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | -3.80 Mn |
| Jun 30, 2024 | -3.80 Mn |
| Dec 31, 2023 | -5.72 Mn |
| Dec 31, 2023 | -5.72 Mn |
| Sep 30, 2023 | 2.42 Mn |
| Sep 30, 2023 | 2.42 Mn |
| Jun 30, 2023 | 250,136.03 |
| Jun 30, 2023 | 250,136.03 |
| Feb 28, 2023 | -170,709.66 |
| Feb 28, 2023 | -170,709.66 |